Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Polyclonal B cell response wikipedia , lookup
Immune system wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Adaptive immune system wikipedia , lookup
Innate immune system wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Optimizing Cancer Treatments under Tumor-Immune System Interactions Urszula Ledzewicz, Department of Mathematics and Statistics, Southern Illinois University Edwardsville, USA We are considering a model that describes the interactions between cancer and immune system as an optimal control problem with the action of a single cytotoxic agent as the control. In the uncontrolled system there exist both regions of benign and of malignant cancer growth that are separated by the stable manifold of a saddle point. The aim of treatment is to move an initial condition that lies in the malignant region into the region of benign growth. A Bolza formulation of the objective is given that includes a penalty term that approximates this separatrix by its tangent space and minimization of the objective is tantamount to moving the state of the system across this boundary. In this talk, generalizing earlier results when the action of the cytotoxic agent on the immune system was assumed negligible, we now consider a killing action of the cytotoxic drug on both the cancer cells and the cells of the immune system. For various values of a parameter ε that describes the relative effectiveness of the drug onto these two classes of cells, we discuss the structure of optimal and near-optimal controls that move the system into the region of attraction of the benign stable equilibrium. In particular, the existence and optimality of a singular arc will be addressed using Lie bracket computations and the Legendre-Clebsch condition.